BERENIL® VET 7% RTU Injection – 30 ML

Manufacturer/Marketer: MSD Animal Health India / Intervet India Pvt. Ltd.
Product Type: Veterinary Antiprotozoal Injection
Therapeutic Category: Haemoprotozoal / Antiprotozoal + Antipyretic
Target Species: Livestock and other label-approved animals
Presentation: 30 ML Glass Vial
Route: Deep Intramuscular (IM) or Subcutaneous (SC)
Prescription Status: Veterinary Prescription Medicine

Composition

Each 1 mL contains:

• Diminazene Aceturate – 70 mg
• Phenazone B.P. – 375 mg
• Water for Injection q.s. to 1 mL 

The product is supplied as a 7% ready-to-use (RTU) diminazene formulation, so no reconstitution is required before administration.

Clinical Description

BERENIL VET 7% RTU is a veterinary haemoprotozoal injection formulated for treatment and control of important blood-parasite infections.

Diminazene Aceturate is an aromatic diamidine antiprotozoal agent active against susceptible haemoprotozoa, particularly organisms responsible for babesiosis and trypanosomiasis.

Phenazone provides antipyretic and analgesic activity, helping control fever and discomfort associated with haemoprotozoal infections.

MSD also lists the product for theileriosis, mixed haemoprotozoan infections and pyrexia of unknown origin. 

Indications / Recommended Uses

BERENIL VET 7% RTU is indicated for the treatment and prophylaxis/control of:

• Babesiosis
• Trypanosomiasis
• Theileriosis
• Mixed haemoprotozoan infections
• Pyrexia of unknown origin, where use is considered appropriate by the veterinarian. 

Dosage & Administration

According to MSD Animal Health India:

Babesiosis & Trypanosomiasis:
5–10 mL per 100 kg body weight

Tenacious Trypanosomiasis:
10 mL per 100 kg body weight

Theileriosis & Mixed Infections:
5–10 mL per 100 kg body weight

Maximum total dose: 56 mL. 

The preferred administration route is deep intramuscular injection or subcutaneous injection at the side of the neck. 

Dose and treatment regimen should be determined by a registered veterinarian.

Key Benefits

BERENIL VET 7% RTU provides a convenient ready-to-use antiprotozoal formulation for major haemoprotozoan diseases.

Key advantages include:

• Activity against Babesia
• Activity against Trypanosoma
• Use in theileriosis and mixed haemoprotozoan infections
• Phenazone for associated fever and pain
• Ready-to-use injection, eliminating the need for reconstitution
• Flexible IM or SC administration according to veterinary direction. 

Precautions

Use only under the supervision of a Registered Veterinary Practitioner.

Calculate the dose accurately according to body weight and the condition being treated.

Do not exceed the total recommended dose of 56 mL. 

Diagnosis of haemoprotozoal disease should ideally be supported by appropriate clinical and laboratory examination because conditions such as babesiosis, theileriosis and trypanosomiasis may produce overlapping clinical signs.

Withdrawal Period

According to MSD Animal Health India:

Meat: 20 days
Milk: 3 days 

These withdrawal periods should be observed when the product is administered to food-producing animals.

Possible Adverse Effects

As with injectable veterinary medicines, occasional local injection-site reactions or hypersensitivity may occur.

Incorrect dosing or excessive administration of diminazene can increase the risk of toxicity. Any unusual neurological, gastrointestinal or systemic signs following treatment require prompt veterinary attention.

Storage

Store below 30°C.
Protect from light.
Avoid freezing. 

Keep the vial properly closed and store according to the instructions on the current product label.

Important Warning

FOR ANIMAL TREATMENT ONLY. NOT FOR HUMAN USE.

BERENIL VET 7% RTU is an injectable veterinary antiprotozoal medicine and should be administered under veterinary supervision.

Observe the recommended dose, maximum total dose, meat withdrawal of 20 days and milk withdrawal of 3 days. 

Rayavets Short Description

BERENIL VET 7% RTU Injection 30 ML by MSD Animal Health is a ready-to-use veterinary antiprotozoal/haemoprotozoal injection containing Diminazene Aceturate 70 mg/mL + Phenazone B.P. 375 mg/mL. It is indicated for the treatment and control of babesiosis, trypanosomiasis, theileriosis and mixed haemoprotozoan infections, and is also listed for pyrexia of unknown origin. The recommended dose for babesiosis, trypanosomiasis, theileriosis and mixed infections is generally 5–10 mL/100 kg body weight, depending on the condition, administered by deep IM or SC injection. Maximum total dose should not exceed 56 mL. Meat withdrawal: 20 days; Milk withdrawal: 3 days. Store below 30°C, protect from light and avoid freezing. For veterinary use only.